Regencell Bioscience
RGC
4.18
-0.18
-4.13%
Regencell Bioscience
US · RGC
#2393 by market cap
Listed 2021
4.18
-0.18
-4.13%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:34
Recent news
-
RGC Resources, Inc. Schedules Third Quarter 2026 Earnings CallGlobeNewswire · 2026/7/25
-
Company notice
RGC Resources | 4: Statement of changes in beneficial ownership of securities-Director Archer Jacqueline L.SEC · 2026/10/3
-
RGC Resources, Inc. Schedules Second Quarter 2026 Earnings CallGlobeNewswire · 2026/4/25
-
Press Release: RGC Resources, Inc. Reports First Quarter 2026 EarningsDow Jones · 2026/2/6
-
Company notice
RGC Resources | 4: Statement of changes in beneficial ownership of securities-Officer Oliver Lawrence T.SEC · 2026/11/5
-
RGC Resources Keeps Quarterly Dividend at $0.2175 a Share, Payable Aug. 3 to Shareholders of Record July 17MT Newswires · 2026/6/30
-
Rating change
Janney Trims Price Target on RGC Resources to $28 From $29, Maintains Buy RatingMT Newswires · 2022/12/6
-
Company notice
4: RGC Resources | 4: Statement of changes in beneficial ownership of securities-Director Archer Jacqueline L.SEC · 2026/7/2
-
Company notice
RGC Resources | 4: Statement of changes in beneficial ownership of securities-Officer Oliver Lawrence T.SEC · 2026/10/3
-
US Stock Movement | Regencell Bioscience (RGC.US) Surges Over 16% Despite Having No Approved Products YetZhitong Finance · 2026/3/18
-
Rating change
Janney Cuts Price Target on RGC Resources to $27 From $28, Keeps Buy RatingMT Newswires · 2023/8/9
-
Rating change
TR | OpenAI - 4o Maintains RGC Resources(RGCO.US) With Buy Rating, Cuts Target Price to $23.5Market Newswire · 2025/8/12
-
Company notice
RGC Resources | 4: Statement of changes in beneficial ownership of securities-Director Archer Jacqueline L.SEC · 2026/11/5
-
Company notice
4: RGC Resources | 4: Statement of changes in beneficial ownership of securities-Officer Oliver Lawrence T.SEC · 2026/6/4
-
Company notice
4: RGC Resources | 4: Statement of changes in beneficial ownership of securities-Officer Oliver Lawrence T.SEC · 2026/7/2
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:34:41 · For reference only, not investment advice and not tailored to your situation.
Regencell Bioscience discussion 0 comments